Regulatory & Reimbursement News, In Brief
Some AHRQ research activities expected to shift to PCORI in White House 2013 budget request. Confusion over non-preferred pharmacy networks in Medicare Part D noted by CMS. Pharmacist organization RxAlly launches with focus on medication adherence.
You may also be interested in...
The contracting dispute between the drug chain and PBM may also presage tougher negotiations ahead for biopharmaceutical companies, particularly if Express Scripts is successful in its bid to acquire rival PBM Medco.
Proposed class action lawsuit by Blue Cross Blue Shield of Minnesota against Vyera Pharmaceuticals could set a precedent for other health insurer actions against manufacturers.
Without Republican support, Biden’s HHS nominee couldn’t get a majority in the Finance Committee, but that shouldn’t imperil his bid to become secretary of Health and Human Services.